Table 6.
Characteristics | PFS | OS | ||||
---|---|---|---|---|---|---|
HR | 95% CI | P-value | HR | 95% CI | P-value | |
Age groups | 0.008 | – | ||||
≤50y (reference) | 1 | – | – | |||
>50y | 0.321 | 0.138–0.747 | – | – | ||
PNI | 0.066 | – | ||||
Negative (reference) | 1 | – | – | |||
Positive | 6.698 | 0.88–51.002 | – | – | ||
Tumor grading | <0.001 | 0.001 | ||||
Grade I–II (reference) | 1 | 1 | ||||
Conventional Grade III | 5.035 | 1.979–12.814 | 0.001 | 1.77 | 0.318–9.849 | 0.514 |
HGT | 9.616 | 3.222–28.697 | <0.001 | 10.728 | 2.998–38.393 | <0.001 |
PORT | 0.002 | 0.024 | ||||
Yes (reference) | 1 | 1 | ||||
No | 3.895 | 1.636–9.273 | 4.336 | 1.214–15.489 |
PFS, progression-free survival; OS, overall survival; HR, hazard ratio; CI, confidence interval; HGT, high-grade transformation; PORT, postoperative radiotherapy.